Surgical Site Infections in Cancer Patients with Intrathecal Drug Delivery Devices: Table 1 | Zendy

Maura M. Scanlon | Zendy; Halena M. Gazelka | Zendy; Susan M. Moeschler | Zendy; Bryan C. Hoelzer | Zendy; W. Michael Hooten | Zendy; Markus A. Bendel | Zendy; Tim J. Lamer | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Surgical Site Infections in Cancer Patients with Intrathecal Drug Delivery Devices: Table 1

Author(s) -

Maura M. Scanlon,

Halena M. Gazelka,

Susan M. Moeschler,

Bryan C. Hoelzer,

W. Michael Hooten,

Markus A. Bendel,

Tim J. Lamer

Publication year - 2016

Publication title -

pain medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.893

H-Index - 97

eISSN - 1526-4637

pISSN - 1526-2375

DOI - 10.1093/pm/pnw203

Subject(s) - medicine , incidence (geometry) , population , cancer , surgery , retrospective cohort study , physics , environmental health , optics

Our purpose was to determine the incidence of surgical site infection (SSI) in cancer patients receiving an intrathecal drug delivery system (IDDS) and compare that rate with the incidence of SSI in the general population receiving an IDDS or spinal cord stimulator. We attempted to describe risk factors for SSIs in cancer patients treated with IDDS in terms of exposure to cancer treatments.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research